Belite Bio
Belite Bio focused on first-in-class therapeutics targeting untreatable inherited orphan diseases and age-related metabolic diseases, including atrophic age-related macular degeneration, stargardt disease, and nonalcoholic steatohepatitis. They develop anti-RBP4 therapies to treat age-related metabolic diseases, including macular degeneration, liver disease, and diabetes. Their technology platform effectively reduces circulating levels of RBP4, a vitamin A transporter protein linked to the development of aging metabolic diseases, including dry age-related macular degeneration, liver disease, and diabetes.
Domain
belitebio.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$350.0M
Founded
2017
Tech Stack (16 technologies)
Frequently Asked Questions
What technologies does Belite Bio use?+
Belite Bio uses 16 technologies including Divi, reCAPTCHA, WordPress.
What industry is Belite Bio in?+
Belite Bio operates in the Biotechnology industry.
Where is Belite Bio based?+
Belite Bio is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026